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1. Introduction 
1.1 Ionizing radiation 
Human exposure to ionizing radiation is a natural part of life on earth. These exposures 
occur every day from radiation associated with naturally occurring radionuclides in soil, air, 
and food, and also from cosmic rays. In addition, many people are exposed to dental and 
medical diagnostic procedures and therapy involving: x rays, gamma rays, charged 
particles, radionuclides, or other ionizing radiation sources. Others may be exposed in their 
workplace such as in laboratories, hospitals, underground mines, or nuclear power plants. 
Excessive exposures may lead to the development of cancer by promotion of ongoing 
carcinogenic biological processes or by independent cancer induction.  
Ionization converts a neutral atom to a charged atom. The Ǆ rays and x rays are ionizing 
electromagnetic radiation with energies above ultraviolet in the electromagnetic spectrum. 
The difference between x rays and Ǆ rays is a matter of nomenclature. The Ǆ rays are emitted 
from the nucleus of a radioactive atom while x rays originate in the orbital electrons of a 
energized atom. The ǂ2+ particle has been identified as a positively charged helium nucleus 
with 2 protons and two neutrons emitted from the nucleus of certain radionuclides. The ǃ- 
radiation was identified as negatively charged electrons emitted from the nucleus of certain 
radionuclides. There are other types of ionizing radiation including most prominently 
uncharged neutrons emitted from the nucleus of atoms that ionize atoms via nuclear 
interactions, and positrons and that are positive beta particles, ǃ+. The measure of absorbed 
radiation dose in matter or tissue is the gray (Gy) equal to one joule of energy per kilogram 
of matter or tissue. To account for different types of ionizing radiation, such as gamma, 
alpha, and beta radiations, the dose from ionizing radiation is corrected for the theoretical 
relative biological effectiveness of the different radiations in causing cellular damage using a 
radiation weighting factor, wR (Sv/Gy), and this is reported as the equivalent dose in 
sieverts (Sv). Hence, the measure of biological dose is the sievert (Sv), equal to the absorbed 
dose in Gy times the radiation weighting factor. The Ǆ rays, x rays, and ǃ radiation typically 
have a radiation weighting factor of 1, while ǂ radiation has a radiation weighting factor of 
20 and neutrons may have a radiation weighting factor from 5 to 20 depending on energy. 
The quantity of radioactivity is measured in becquerel (Bq), equal to one radioactive atomic 
event or nuclear disintegration per second. 
Radiation induced cancer is a complex and not completely understood process involving 
multiple events including but not limited to cellular DNA damage, up and down regulation 
of genes, intercellular communication, tissue and organ responses, clonal expansion of 
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altered cell lines, and possibly eventual malignancy. The current understanding of radiation 
carcinogenesis is informed by epidemiological studies of human populations exposed to 
elevated levels of ionizing radiation and controlled studies utilizing laboratory animals. The 
two major human epidemiological studies have led to sharply contrasting results. Studies of 
the atomic bomb survivors indicate a linear no-threshold dose-response relationship. Studies 
of the radium dial painters have led to a sharp threshold relationship. These contrasting 
findings occur because quite different mechanisms of ionizing radiation carcinogenesis are 
involved in brief acute exposures at relatively high dose rates and in protracted exposures. 
Brief acute high dose-rate exposures act by promoting ongoing biological processes that lead 
to cancer in later life and this promotion effect is proportional to the dose. Protracted 
exposures induce cancer with a latency that depended on the lifetime average dose-rate of 
exposure to the target organ. At low dose rates the latent period may exceed the natural 
lifespan leading to a lifetime virtual threshold for cancer induction. Another observation at 
lower dose rates is the amelioration of an ongoing pre-malignant process. These findings have 
important implications with respect to ionizing radiation safety standards. 
1.2 Naturally occurring ionizing radiation and radioactivity 
There are naturally occurring sources of ionizing radiation that have existed on the planet 
since its formation (Eisenbud & Gesell, 1997). Naturally occurring radiation sources include 
cosmic rays, cosmogenic radionuclides, and primordial radionuclides and their decay 
products. Cosmic rays consist primarily of extremely high energy (mean energy ~ 10 billion 
electron volts) particulate radiation (primarily protons) and high energy gamma rays. When 
the particulate radiations collide with the earth's atmosphere a shower of "secondary" 
radiations are produced, which include high energy electrons and photons. The average 
person’s dose from cosmic radiation is 0.27 mSv per year or ~ 7% of natural background. 
Exposure to cosmic radiation increases with altitude as there is less atmosphere to absorb 
the radiation, so populations at high elevations receive higher cosmic doses. For example, 
people living in Leadville, Colorado, at 3,200 meters above sea level, receive ~ 1.25 mSv y−1 
or five times the average exposure at sea level. A fraction of the secondary particulate 
cosmic radiation collides with stable atmospheric nuclei making them radioactive. These 
cosmogenic radionuclides contribute very little (~ 0.004 mSv y−1 or less than 1%) to natural 
background radiation. The majority of this component of natural background is from the 
formation of carbon-14 and tritium (hydrogen-3). 
Terrestrial radioactive materials that have been present on earth since its formation are 
called primordial radionuclides. Population exposure from primordial radionuclides comes 
from external exposure, inhalation, and incorporation of radionuclides into the body. The 
decay chains of 238U, whose half-life is 4.5 billion years (uranium series), and 232Th, whose 
half-life is 14 billion years (thorium series), produce several dozen radionuclides that 
together with natural potassium-40, whose half life is 1.3 billion years, are responsible for 
the majority of the external terrestrial average equivalent dose rate of 0.28 mSv per year or 
~9% of natural background. Traces of these primordial isotopes of uranium and thorium are 
found in all the soil and rock on the face of the earth. Some regions of the world with high 
concentrations of primordial radionuclides produce local equivalent dose rates of 
environmental gamma radiation as high as 25 mSv per year. 
Radon, 222Rn, and its decay products, which are constituents of the 238U decay series (Fig. 1), 
are the most significant source of natural background radiation exposure. Once inhaled, the 
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majority of the dose is deposited in the tracheobronchial region by its short-lived daughters 
rather than by 222Rn itself. Radon concentrations in the environment vary widely due to 
differences in 238U concentration in the soil and differences in ventilation and construction of 
buildings. All other factors being equal, buildings with less ventilation will tend to have 
higher radon concentrations and thus, higher level of background radiation exposure. 
Outdoor concentrations of radon and its decay products are normally low because of the 
rapid mixing and dilution of radon gas with ambient air. 
 
 
Fig. 1. Schematic illustration of the natural 238U decay series as found in all soil and rock on 
the surface of planet Earth. 
The second largest source of natural background radiation exposure comes from the 
ingestion of food and water that contain primordial radionuclides (and their decay 
products) of which 40K is the most important. Altogether this pathway is responsible for an 
average effective dose rate of 0.4 mSv y−1, or ~ 13% of natural background. 
1.3 Typical human exposures to ionizing radiation 
Every person who has ever lived has been exposed to ionizing radiation every minute of 
every day. Among the natural exposures are radiation emitted by nuclides naturally found 
on the earth (3% terrestrial background), internal exposure to natural radionuclides in food 
and water (5% internal background), cosmic radiation (5% space background), and radon 
and thoron gases released from the earth by the decay of naturally occurring radium 
isotopes (37% radon isotopes alpha irradiation of the lung). A major change has occurred 
here in the 21st Century from increased exposures that may occur through medical 
diagnostic use of x rays and radionuclides.  
The average per capita “effective” radiation dose in the United States from naturally 
occurring (or "background") sources is about 3 mSv) per year. The “effective” dose is 
calculated using the International Commission on Radiological Protection (ICRP) 
methodology in which a tissue weighting factor is assigned to each organ or tissue and 
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multiplied by the actual equivalent dose to the organ or tissue (ICRP 26, 1977). In the United 
States diagnostic medical radiology and nuclear medicine now add about 3 mSv of effective 
dose to ionizing radiation exposure per year per average person. The percent average 
contribution of various sources of ionizing radiation exposures of typical residents of the 
United States population in 2006 is illustrated in a pie-chart (Fig.2) prepared by the National 
Council for Radiation Protection and Measurement. 
 
 
Fig. 2. Percent contribution of various sources of exposure to ionizing radiation to the 
average annual effective dose (6.2 mSv) per person in the United States population (about 
300 million people) in 2006 (NCRP 160, 2009). 
There are many places on the earth where natural background doses are much higher 
because of the natural presence of high concentrations of naturally occurring radionuclides 
in soil, rock, and water. Studies of these areas of naturally elevated ionizing radiation have 
not yielded any major deleterious effects associated with these natural exposures. For 
example, people in some areas of Ramsar, Iran, receive an annual ionizing radiation 
biological dose from natural background that is up to 260 mSv per year (over 40 times the 
USA national average). Chromosomal, hematological, and immunological studies and life 
span and cancer data show no untoward effects or responses (Ghiassi et al., 2002). 
1.4 Naturally occurring radium isotopes and decay products 
There are many naturally occurring radioactive nuclides that are continually being 
produced from decay chains in which the parent has a very long physical half life. For 
example, 226Ra that is present in all the soil and rock on the earth at concentrations of about 
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25 Bq kg−1 is a product of the decay series headed by 238U whose half life is comparable to 
the age of the earth (4.5 billion years). Consequently, it is also naturally found in ground water 
and the human body, usually in trace amounts (about 1 Bq per person). The 238U decay series 
is shown in Figure 1. As shown in the figure, various types of ionizing radiation are emitted by 
the radionuclides in the chain including alpha radiation (ǂ2+), beta radiation (ǃ–) and gamma 
radiation (Ǆ). In addition, similar or smaller amounts of natural 228Ra, a decay product of 
natural 232Th, are also found in soil and water. A similar 232Th decay chain yields 228Ra, 228Ac, 
228Th, 224Ra, 220Rn, 216Po, 212Pb, 212Bi, 212Po, and stable 208Pb (Eisenbud & Gesell, 1997). 
As an analogue of calcium, radium that enters the body tends to incorporate into mineral 
bone where it and its progeny irradiate portions of the skeleton, primarily by alpha 
radiation emissions. Thorium isotopes tend to deposit on bone surfaces and irradiate surface 
cells, primarily by alpha radiation emissions. The radionuclide undergoing decay is referred 
to as the parent nuclide and the transformed nuclide is called the daughter or decay 
product. The daughter may be no more stable than its parent and may also be radioactive. 
Successive transformations will occur in a so-called decay chain, possibly yielding several 
radioactive progeny, until a stable nuclide is reached (Fig. 1).  
In this context for 226Ra, the word dose is used specifically to refer to the mean alpha 
radiation dose absorbed by the irradiated skeleton measured in units of energy deposited 
per unit mass of skeletal tissue (Gy). Dosage refers to the amount of material that enters the 
body or is administered (Bq). Burden refers to the amount retained in the body or skeleton 
with time post intake (Bq). Intake can refer to systemic intake into the blood or other organs 
of the body, as for the U.S. radium cases (Rowland, 1994), or it can refer only to that material 
that passes into the mouth or nose during ingestion or inhalation as in radiation protection 
practice (ICRP-30, 1979). Note that there is a really big difference between ingestion or 
inhalation intake and systemic intake, sometimes a factor of thousands. Cumulative dose, D, 
to an organ of the body is derived from the time integral of concentration (or dose rate) in 
that organ and requires a specified time limit to be meaningful. 
2. Internally deposited radionuclides 
2.1 Radium in people 
Early in the last century people were exposed to high concentrations of 226Ra and 228Ra and 
their decay products in the luminous dial industry, in laboratory work, and in medical or 
private therapeutic use of radium. In particular, luminous-dial painters, who were mostly 
young women, were taught to tip their paint brushes on the tongue to make a sharp brush 
point; this procedure resulted in the ingestion of considerable radium leading to systemic 
uptakes of some of the ingested radium. These massive intakes of emulsions of pure radium 
salts resulted in life-time absorbed doses to the irradiated skeleton of some dial painters as 
high as a few thousand Sv, with consequent cases of severe injury to the skeleton and/or 
bone sarcoma as well as carcinomas of the head associated with retained 222Rn and 
daughters in the nasal sinuses and mastoid spaces.  
Detailed evaluations of these human cases have been described by Evans (1943), Evans et al. 
(1972), Evans (1974) and further documented in recent years (Rowland, 1994). Studies of 
individuals who had accidental intakes of massive amounts of radium have shown that the 
principal risk of exposure to large quantities of radium is direct damage to bone, bone 
cancer (but not leukemia), and cancers of the head caused by trapped decay of radon gas 
produced by decay of 226Ra in the skeleton. It is interesting to note that no person among the 
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U.S. radium dial painters whose skeletal dose was less than 10 Gy ( 200 Sv for ionizing 
radiation weighting factor of 20 for alpha radiation) developed bone cancer because of 
exposure to 226Ra or 228Ra. An effective or virtual threshold dose, below which there is no 
radiation-induced cancer from exposure to radium, has been observed (Evans, 1974; Raabe 
et al., 1980; Raabe, et al., 1990; Raabe, 2010). In addition, serious non-neoplastic (non-cancer) 
radiation bone injury, such a bone osteodystrophy and fractures, occurred at even higher 
doses than did cancer. 
Since deposition in and protracted irradiation of the skeleton follows systemic uptake, even 
a single brief intake initiates a period of chronic irradiation from radium and its retained 
decay products that depends in duration on skeletal retention or radioactive decay of the 
deposited radium. About 30% of radon-222 is retained from decay of radium-226, and 
almost all radon-220 is retained following the decay of radium-224 that forms from the 
decay products of radium-228. In the case of inhalation of radium (or thorium), irradiation 
of the lung is also an important aspect of the exposure. However, radium (or thorium) 
deposited in the lung is cleared by the lymphatic flow, coughed up and swallowed or 
expectorated, or enters the blood. Upon entry into the blood from the lung, inhaled radium 
is mostly excreted in the urine, while about 20% is deposited and tenaciously retained in the 
skeleton. The retention of radium in the human body, particularly the skeleton, has been the 
subject of considerable study and has been described in a mathematical form that allows the 
ionizing radiation dose to body tissues to be estimated from time of systemic intake until 
any time after intake ( ICRP-20, 1973). 
 
 
Fig. 3. Early 20th Century photo of young women painting clock dials with luminous paint 
containing radium. They tipped their brushes on their tongues and swallowed considerable 
quantities of 226Ra or 228Ra. 
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Lifetime studies were conducted in the 20th Century of the American radium dial painters 
(Fig. 3) and others with internally deposited radium isotopes (226Ra and 228Ra). Internally 
deposited radium chemically behaves somewhat like calcium and deposits somewhat 
uniformly in bone mineral in the skeleton. Radium is cleared from the body slowly so that a 
few percent of the intake can still be detected decades after intake. Alpha radiation from 
radium and its decay products lead to bone sarcoma in some exposed people at the highest 
doses. For 226Ra (half life 1,600 years), the first decay product is 222Rn gas much of which 
migrates in the blood to other parts of the body and is exhaled via the lung. Some 222Rn gas 
sequesters in the sinus and mastoid regions of the head where alpha radiation from radon 
and its decay products lead to head carcinoma in some of the most highly exposed people. 
The most extensive studies of people exposed to radium were conducted at Massachusetts 
Institute of Technology (MIT) and Argonne National Laboratory (ANL). Results have been 
reported for over 2,000 people including about 1,700 who had significant intakes of radium, 
mostly to 226Ra (Rowland, 1994). The nuclear physicist, Robley Evans, author of The Atomic 
Nucleus (1955) lead the early studies. Evans observed that only those people who received 
skeletal absorbed alpha radiation doses exceeding 1,000 cGy, developed bone sarcoma (Fig. 
4), which he called a “practical threshold”. He showed that the absence of sarcoma cases 
below 1,000 cGy was a statistically significant finding (Evans et al, 1972). This finding did 
not deter others from reorganizing the data into selective groups of cases and advancing a 
linear no-threshold model for radium induced bone sarcoma (Fig. 5). 
 
 
Fig. 4. Bone sarcoma incidence in people exposed to 226Ra as a function of cumulative dose 
to the skeleton as reported by Evans et al. (1972). 
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Fig. 5. Misleading linear dose-response model fit to bone sarcoma incidence in people who 
were exposed to 226Ra as a function of cumulative dose by Mays and Lloyd (1972). 
2.2 Radium-226 in beagle dogs 
Since human data for exposure to internally deposited radionuclides are usually difficult to 
evaluate and readily confounded, in the late 1950's, the Division of Biology and Medicine of 
the United States Atomic Energy Commission conceived a series of carefully controlled 
scientific studies utilizing purpose-bred dog colonies of pedigreed beagles. These studies 
were conducted primarily at the University of Utah, the University of California, Davis (UC 
Davis), Hanford Laboratory, Richland, Washington, and Lovelace Foundation in 
Albuquerque, New Mexico.  
The largest lifetime study of beagles exposed to 226Ra was conducted at UC Davis from 1961 
to 1989. Dogs were bred in a manner to maintain and randomize the gene pool and entered 
into the study over several years in a randomized-block design so that and all dosage levels 
and controls were represented contemporaneously in each treatment block. Exposure to 
226Ra, temporally simulating the dial painter exposures, were by eight intravenous injections 
two weeks apart in young adults from 435 to 540 days of age (Raabe 1989).  
The distribution of deaths and causes are show in Fig. 6 (Raabe, 2010). The bone sarcoma 
deaths followed a tight lognormal power function of average radiation absorbed dose rate to 
skeleton with geometric standard deviation of only 1.22. Although the induced cancer 
response is a tight power function of dose rate, it is not a meaningful function of cumulative 
dose. For example, at an alpha radiation dose rate of about 0.1 Gy d−1 the median time to 
bone cancer death is about 1,200 days with a total cumulative dose of 120 Gy. In sharp 
contrast, at a alpha radiation dose rate of 0.003 Gy d−1 the median time to bone cancer death 
is about 4,000 days with a total cumulative dose of only 12 Gy. It would seem that the 
radiation is ten times more effective at the lower dose rate than at the higher dose rate, but 
that observation is misleading since it is the dose rate that controls the cancer induction and 
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latent period. It is the lifetime average dose rate that controls the risk of radiation-induced 
cancer. Since the extrapolated bone cancer latent period exceeds the natural life span of the 
beagles at low dose rates, there is a virtual threshold for bone cancer from radium. None of 
the dogs in the lowest dose group developed bone cancer because they died first from 
causes associated with natural aging.  
 
 
Fig. 6. Two-dimensional logarithmic representation of the data for radiation injury deaths, 
bone sarcoma deaths, and other deaths in beagles injected with 226Ra at UC Davis, showing 
time from initial intake at age 435 days to death for each individual dog versus average dose 
rate to skeleton and fitted lognormal risk functions (Raabe, 2010). 
The data shown in Fig. 6 is a two-dimensional representation of a three dimensional 
phenomenon. The three dimensions are lifetime average dose rate to the skeleton, time to 
death, and the frequency distribution of bone cancer deaths (Fig. 7). This three-dimensional 
phenomenon can be expressed in terms of the risk of death from various causes during the 
beagle lifetime (Fig. 8). The occurrence of beagle bone cancer deaths from 226Ra-induced 
cancer is displayed as a mound rising out of a Euclidian plane. At low dose rates there are 
no cases of bone cancer observed because all of the beagles have died of causes associated 
with natural aging. At high dose rates there are radiation injury deaths. 
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Fig. 7. Three-dimensional logarithmic representation of average-dose-rate/time/response 
relationships of Fig. 6, for beagles injected with 226Ra at UC Davis, shown as the probability 
density distribution frequency of the combined risk of dying from causes associated with 
natural life span, radiation-induced bone sarcoma, and radiation injury, as a function of 
average dose rate to skeleton and elapsed time after intake at age 435 days (Raabe, 2010). 
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Fig. 8. Three dimensional representation from Fig. 6 of average-dose-rate/time/response 
relationships for beagles injected with 226Ra at UC Davis shown in the top left panel as the 
combined risk of dying, and in the successive panels as the occurrence of deaths from 
radiation injury, natural life span, and radiation-induced bone sarcoma (Raabe, 2010). 
The common but inappropriate practice of assuming that the cancer induction risk from 
exposure to ionizing radiation is proportional to cumulative radiation dose leads to 
misunderstandings about the true nature of the dose-response relationship. For example, the 
data from the 226Ra beagle study can be plotted in the traditional fashion (Fig. 9). The 
common practice of fitting a linear no-threshold line starting at the zero-zero coordinates 
leads to an imprecise model that completely obscures the virtual threshold at low doses 
shown by the precise relationship to dose rate (Fig. 6).  
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Fig. 9. Two-dimensional representation of the data for radiation-induced bone cancer 
deaths, in beagles injected with 226Ra at age 435 days of age at UC Davis, showing lifetime 
bone sarcoma occurrence as percent of population versus calculated cumulative dose to 
skeleton one year before death. Note the life-span virtual threshold below 1 Gy as shown in 
the inset that would be obscured by a linear no-threshold (LNT) model of these data that 
starts at the origin with the only zero or near-zero risk at zero dose (Raabe, 2010). 
2.3 Human cancer risk from radium-226 
When a three-dimensional analysis is used for an interspecies comparison for radium-
induced cancer, the different species display a similar relationship displaced in time based 
on natural life span (Fig. 10) (Raabe et al., 1980). The greater scatter of data for mice and 
people is the result of uncertainty and inaccuracy for the dose data compared to the precise 
beagle study. When the time scale is normalized with respect to natural lifespan for the 
species, all three sets of data overlay (Fig. 11). These results provided a basis for scaling 
cancer induction dose-response relationships among difference species. For example, the 
precise beagle data can be used to predict radium-induced bone cancer deaths in people by 
life-span normalization. The resulting prediction of median bone cancer risk for people falls 
almost perfectly at the median of the observed risk although the human data are quite 
scattered because of the dosimetric limitations (Fig. 12).  
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Fig. 10. Primary bone sarcoma deaths from 226Ra in people, beagles, and female mice 
showing similar dose-response functions indicated by parallel median lines with negative 
slope of about one-third and tL are the typical life spans for the three species (Raabe et al., 
1980). 
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Fig. 11. Life span normalization with respect to dimensionless time and average alpha 
radiation absorbed dose rate to skeleton for fatal bone sarcoma in beagles, mice and people 
(Fig. 10) showing a single logarithmic regression line (determined for beagles) represents the 
median risk for all three species (Raabe, 2010). 
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Fig. 12. Distribution of deaths for beagles and predicted distribution of deaths for people 
exposed to 226Ra along with human data from the U.S. radium studies (Raabe, 2010). 
Another form of alpha radiation-induced cancer occurs in people but not in laboratory 
animals. The radioactive decay of 226Ra yields 222Rn gas, much of which enters the blood 
stream and some of which sequesters in the nasal sinus and mastoid region of the head 
which leads to alpha irradiation of the internal tissues in these regions of the head from 
radon and its decay products. These deaths are somewhat delayed in time. The resulting 
three-dimensional frequency distribution of causes of death in people with internally 
deposited 226Ra is shown in Fig. 13. Both head carcinoma and bone sarcoma display virtual 
threshold cancer risk relationships at low doses and dose rates. 
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Fig. 13. Three-dimensional representation of the average-dose-rate/time/response 
relationships for people after intake of 226Ra shown in the top middle panel as the 
cumulative risk of dying, in the top left panel as the occurrence of deaths associated with 
natural life span, in the top right panel as the occurrence of deaths from radiation injury to 
the skeleton, in the lower panels have the occurrence percent of deaths from radiation-
induced head carcinoma and bone sarcoma, respectively (Raabe, 2010). 
2.4 Strontium-90 in people 
Radioactive 90Sr (half life 29 years), a product of nuclear fission of uranium and plutonium, 
has been released into the atmosphere of the earth by nuclear weapons in Japan in 1945, by 
numerous atmospheric nuclear weapons tests up until 1966, and by the Chernobyl nuclear 
reactor accident in Russia in 1986. Strontium is chemically similar to calcium and deposits 
somewhat uniformly in bone mineral in the skeleton. Released to the environment, 
strontium is adsorbed and retained by clay in soil, and is found in small amounts in 
agricultural food products. The 90Sr, a beta particle emitter, decays to 90Y, a short-lived beta 
particle emitter that decays to stable 90Zr. Everyone born in the Northern hemisphere after 
about 1950 probably has measurable trace amounts 90Sr in bones and teeth. 
2.5 Strontium-90 in beagle dogs 
Because of the widespread exposure of people to 90Sr from nuclear weapons testing in the 
20th Century, the U. S. Atomic Energy Commission initiated controlled studies of ingested 
90Sr in purebred beagles. The largest lifetime study of beagles exposed to 90Sr by ingestion 
was conducted at UC Davis from 1961 to 1989 in parallel with the study of injected 
226Ra.Dogs were bred in a manner to maintain and randomize the gene pool and entered 
into the study over several years in a randomized-block design so that and all dosage levels 
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and controls were represented contemporaneously in each treatment block. Exposed beagles 
received measured amounts of 90Sr in food via the mother during mid-gestation and via 
their food through adulthood at 540 days of age. The exposed young adult beagles in the 
study had bones and teeth that were uniformly labeled with 90Sr. The controls were fed food 
with a high-dose mass equivalent of non-radioactive stable natural strontium, mostly 88Sr 
(Raabe & Parks, 1993).  
Unlike the short-range alpha radiation from 226Ra and decay products in bone that 
irradiated primarily the bone mineral of the skeleton, the longer-range beta radiation from 
90Sr-Y irradiated the bone mineral, the bone marrow, tissue and tissues adjacent to bone and 
teeth. Induced cancer deaths were associated with four different types of cancer: (a) bone 
sarcoma, (b) periodontal carcinoma, (c) oral carcinoma, and (d) leukemia. Each of these 
displayed a virtual threshold relationship (Fig. 14). Although there were 2 cases of bone 
sarcoma deaths among the 80 controls, there were no cases among the 183 exposed beagles  
 
 
Fig. 14. Statistical evaluation by survival analysis (Peto et al. 1980) of the incidence of fatal 
leukemia, bone sarcoma, and carcinoma in beagles fed 90Sr from before birth to adulthood at 
UC Davis demonstrating a life-span virtual threshold with all radiation-induced cancers 
occurring at calculated cumulative skeletal beta radiation doses above 20 Gy (20 Sv). The 
absence of bone sarcoma in the lowest three dosage groups is significantly less than those 
found in the controls (p<0.047)(Raabe, 2010). 
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Fig. 15. Comparison of bone sarcoma in beagles at UC Davis from injected 226Ra and 
ingested 90Sr (Raabe, 2010). 
in the three lowest dose groups. The chance of this is p=0.092 (Fisher’s Exact Test). Among 
all 162 controls in the 226Ra and 90Sr studies there were 2 fatal bone sarcoma cases and two 
with bone sarcoma that died of other causes. With 4 bone sarcoma cases among 162 controls, 
the absence of bone sarcoma cases in the three lowest 90Sr dose groups is a statistically 
significant reduction in tumor cancer incidence with p=0.047 (Fisher’s Exact Test). The shape 
of the dose response relationship for 90Sr-induced bone sarcoma is similar to that for 226Ra 
except it follows a Weibull distribution and the power function slope is twice as steep as for 
226Ra indicating that an average of two beta particles are needed to equal the effect of one 
alpha particle for induction of bone cancer (Fig. 15).  
2.6 Inhaled, ingested, and injected radionuclide studies in beagles 
An analysis of 25 lifetime studies of inhaled, ingested, and injected internally-deposited 
radionuclides in beagles show remarkable consistency (Raabe, 2010). Three-dimensional 
models have been fit to selected data from life-time studies of internally deposited 
radionuclides in young adult beagles at four laboratories: University of California, Davis 
(Raabe and Abell, 1990), Lovelace Inhalation Toxicology Research Institute (ITRI) and 
University of Utah (Mauderly and Daynes, 1994), and Battelle Pacific Northwest Laboratory, 
PNL (Park et al., 1993). Dose response data were evaluated for beagles with skeletal burdens 
of 90Sr after exposure by ingestion at Davis, by injection at Utah, and by inhalation at ITRI, 
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for lung burdens of inhaled 144Ce, 91Y, and 90Sr in fused aluminosilicate particles (FAP) at 
ITRI, inhaled 239Pu dioxide at PNL, skeletal burdens of injected 226Ra at Davis and Utah and 
inhaled 238Pu at ITRI, and skeletal burdens of injected 228Ra and 241Am at Utah. Analyses 
were based on the mean organ absorbed doses to to the target tissues from parent and 
corresponding doses from decay products in their appropriate proportion, where all x ray 
and gamma emissions were ignored because of their minor contribution, and where beta 
emissions are also ignored in the cases where the primary exposures were from alpha 
radiation. Overall, there were separate injection studies of 226Ra, 228Ra, 224Ra, 228Th, 239Pu, 
249Cf, 252Cf, 241Am and 90Sr. There were separate inhalation studies of 239Pu, 238Pu, 90Y, 91Y, 
90Sr, and 144Ce (Raabe, 2010).  
 
 
Fig. 16. Summary of bone sarcoma and lung carcinoma risk functions for beagles 
demonstrating similar target organ dose-rate/time/response patterns illustrating the life-
span virtual thresholds at low dose rates. The positions of the lines vary because of inherent 
differences in irradiation of the target cells by the different radionuclides. Data were selected 
from life-time laboratory studies of internally deposited radionuclides in young adult 
beagles including skeletal deposits of 90Sr after exposure by ingestion at Davis, by injection 
at Utah, lung deposits of inhaled 144Ce, 91Y, and 90Sr in fused aluminosilicate particles (FAP) 
at ITRI, lung deposits of inhaled 239PuO2 at PNL, skeletal deposits of injected 226Ra at Davis, 
inhaled 238PuO2 at ITRI, and skeletal deposits of injected 228Ra and 241Am at Utah (Raabe, 
2010). 
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A selection of these results are shown in Fig. 16. All of the alpha radiation studies followed 
lognormal distributions with power function slope of negative one-third. All of the beta 
radiation studies followed Weibull distributions with power function slope of negative two-
thirds. The different positions of these functions were shown to be associated with the 
efficiency of irradiation of the target sensitive tissue in each case. At low dose rates and 
associated low life-time cumulative doses there was a virtual threshold for ionizing 
radiation induced cancer. For young adult beagles, bone sarcoma induction from alpha-
emitting or beta-emitting radionuclides was unlikely for cumulative doses below about 20 
Sv delivered specifically to the sensitive tissues at bone surfaces. For inhaled alpha-emitting 
radionuclides lung carcinoma was unlikely for cumulative lung doses less than 10 Sv and 
for inhaled beta-emitting radionuclides lung carcinoma was unlikely for cumulative lung 
doses less than 5 Sv (Raabe 2010). 
3. Radon exposures 
3.1 Environmental radon  
All of the earth's atmosphere contains low concentrations of radioactive airborne particles 
and gases associated with various naturally occurring radionuclides. Of particular interest 
are radioactive isotopes of the inert gas, radon. Three radioactive isotopes of the radon gas 
219Rn from the natural 235U decay series, 220Rn from the natural 232Th decay series and 222Rn 
from the natural 238U decay series are produced in earth’s crust and released by diffusion 
into the outdoor air. The 222Rn with a decay half-life of 3.82 days is therefore the most 
important. In some cases 220Rn, commonly called thoron, can be important also. The 238U 
decay series that yields 222Rn and its decay products is shown in Figure 1. The 222Rn is the 
decay product of the naturally occurring radium isotope 226Ra that occurs naturally in all the 
soils and rock on the surface of the earth at concentrations of about 25 Bq kg−1. 
Consequently, 226Ra is also naturally found in ground water and the human body, usually in 
trace amounts (about 1 Bq per person). When 226Ra undergoes radioactive decay (half-life 
1,600 y) it forms gaseous 222Rn, which can percolate through and diffuse out of the soil or 
rock and into the air. This process has definite temporal limits since the half-life of 222Rn is 
only about 3.8 d. However, enough radon reaches to the earth's atmosphere to provide an 
average outdoor concentration of about 10 Bq m−3 in outdoor air in the most populated part 
of the world. Much lower concentrations occur over the oceans and in cold polar locations. 
The 222Rn decays in air to form radioactive, solid decay products that form radioactive 
aerosols. In addition to 226Ra, similar or smaller amounts of 228Ra, a decay product of 232Th, 
are also found on the earth leading to the atmospheric release of the radon gas isotope, 
thoron, 220Rn. However, the concentration of thoron and its decay products is usually 
negligible in comparison the 222Rn and its decay products. Very high air concentrations of 
radon can be found in some mines and elevated levels can be found in most buildings.  
When air containing radon gas is inhaled by a person, a small amount of this inert gas 
dissolves in body fluids. During its radioactive decay emitting an alpha particle and the 
following decay of its decay products some cells of the body are irradiated, but the level of 
whole body irradiation is quite small. Much more important is the irradiation of the lungs 
associated with the deposition in the bronchial airways of the radon decay products which 
are solid metal atoms rather than gases. While radon gas is inhaled and exhaled, the 
unattached decay products and those attached to small inhalable airborne particles can 
deposit in the bronchial airways of the lungs during normal breathing. For example, in the 
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case of 222Rn , the short-lived alpha-particle emitting isotopes of polonium, 218Po and 214Po, 
that deposit in the lungs can result in relatively high alpha-particle irradation of bronchial 
airways. The comparatively small dose associated with the beta-particle emitting decay 
products is insignificant compared to the alpha irradiation which is about 20 times more 
biologically effective than beta radiation per unit of energy. The equivalent dose to the 
bronchial airways from radon and thoron decay products in ambient air in homes for the 
average person in the USA has been estimated to be about 28 mSv per year (NCRP 160, 
2009). In some areas of the USA, the annual dose to the bronchial airways from radon and 
thoron may be double this average value. 
Given sufficient time and other favorable conditions, the decay products of 222Rn will come 
into radioactivity equilibrium with the radon with each of the short-lived decay products 
having the same activity concentration in the air as the 222Rn. However, this ideal 
equilibrium is rarely attained in air containing elevated levels of radon so that measurement 
of the radon gas concentration does not precisely indicate the concentration of decay 
products unless that state of disequilibrium is known. Since essentially all of the biologically 
important radiation dose to the respiratory epithelium is derived from the alpha-emitting 
radon decay products, their concentration is sometimes described in special units called the 
working level, WL. The WL unit is defined as any combination of the short-lived radon 
progeny in one liter of air that will result in the emission of 130,000 MeV of alpha particle 
energy. Air having a 222Rn concentration of 3.7 kBq m−3 with the progeny in secular 
equilibrium would represent 1 WL. The exposure associated with a typical work month in a 
uranium mine for 170 h at 1 WL is called an exposure of 1 working level month, WLM. 
Dosimetric models indicate that the nominal dose to the bronchial epithelium associated 
with inhalation of radon decay product aerosols by a uranium miner is about 6 mGy/WLM. 
Assuming an alpha radiation weighting factor of 20, this yields about 120 mSv equivalent 
dose per WLM to the bronchial region of the lung. 
Upon inhalation, the airborne particles containing radon decay products may deposit upon 
contact onto the surfaces of the respiratory airways. Because of their diffusivity, the very 
small molecular clusters may efficiently deposit in the head airways or in the trachea and 
bronchial airways of the lung. Other somewhat larger particles may reach the alveolar 
region of the lung, as well. Because of their short radioactive half-lives, they usually decay 
prior to being cleared from the respiratory tract and irradiate the respiratory epithelium. Of 
primary concern in this regard is the irradiation of the bronchial epithelium by the highly 
ionizing alpha radiation emitted by radium-A (218Po) and radium-C' (214Po). Since radon 
itself is an inert gas, it does not readily deposit in the respiratory airways during inhalation 
and is mostly exhaled. Occasionally an atom of radon gas may decay and emit alpha 
radiation in air present in the lung irradiating the epithelium, but the fraction of the dose 
contributed by the radon itself is small compared to that associated with the deposited 
decay product particles. Because naturally occurring radon decay products are in ambient 
air outdoors and within a building, the lung is the most highly irradiated organ of the body 
of a typical person from background radiation sources.  
3.2 Radon and radon decay product dosimetry 
The dosimetry methodology associated with estimating the alpha radiation dose to the 
lungs of people from exposure to atmospheres containing radon and thoron is quite 
complicated and the dosimetry estimates are subject to quite large uncertainties. Consider 
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the case of radon gas entering an air space as it diffuses from the earth. Initially there are no 
decay products since they are produced as the radon atoms decay and convert from gas 
atoms to metallic atoms. This in-growth of 218Po (commonly called Ra-A), 214Pb (commonly 
called Ra-B), and 214Bi (commonly called Ra-C) is shown graphically in Figure 17 for a 
concentration of radon equal to 3.7 kBq m−3 which at decay-product equilibrium is the level 
commonly called one working level (WL) associated with underground mining. While 218Po 
comes to equilibrium with radon in about 20 minutes, it takes more than 2 hours for 214Pb 
and 214Bi to approach equilibrium. In that time more radon is entering the airspace, 
ventilation is changing the relative concentrations, and the metallic decay products are 
being surrounded by water molecules, are undergoing Brownian diffusion and are attaching 
to larger airborne particles and onto the surfaces of walls, floor, ceiling, furniture, and 
people. Measurements that are made of radon gas concentrations in a living space or 
underground mine do not describe the concentration of the airborne solid decay products 
that deliver more than 90% of the dose the bronchial airways of people in that room or 
underground mine. 
 
Fig. 17. Ingrowth of radon decay products as a function of time starting with 3.7 kBq m−3 of 
222Rn yielding one working level, WL. 
As each radon gas atom in air decays by emitting alpha radiation it forms an atom of 
radioactive polonium, 218Po (called radium-A, half-life about 3 minutes). This metallic atom 
quickly oxidizes and forms the center of a particulate molecular cluster of about 8 Å in 
diameter. When it decays emitting alpha radiation, a series of short-lived decay products are 
formed in air. These also form particulate clusters. This radon decay process is shown 
schematically in Fig 1. The long-lived lead isotope, 210Pb (half-life 22.3 y) provides negligible 
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radioactivity to the atmospheric aerosols and is, in effect, virtually non-radioactive 
compared to its short-lived progenitors. These radon decay product clusters represent the 
smallest airborne particles normally found in ambient air. In addition, these clusters attach 
upon contact to other, larger airborne particles to an extent that depends upon their 
concentration. Typically, more than 90% of radon decay product aerosols are associated 
with particles smaller than 0.5 μm in aerodynamic diameter. 
Actually, the dosimetry is even more complicated. The deposition of airborne particles in 
the bronchial airways during inhalation is a function of the aerodynamic and diffusive 
properties of the airborne particles to which the radon decay products attach (ICRP 66, 
1994). This depends on both the size distribution and concentration of the the airborne 
particles in the air. When the concentration of airborne particles is quite small, many of the 
decay products may not be attached to a larger particle (the so called unattached fraction). 
The unattached fraction efficiently attaches in all parts of the airways because of Brownian 
diffusion properties of very small particles causing somewhat efficient deposition in the 
upper airways of the nose and throat as well as the small bronchial airways. The irradiation 
of the living cells occurs primarily after the airborne particles deposit on the surface of the 
airways. If the radon decay products are associated with larger airborne parrticles, the 
deposition in the lung may be less because some of the inhaled particles may be exhaled. If 
the airborne particles are relatively large, they may deposit in the nose and throat and not 
readily reach the bronchial airways. Both the concentration and the aerodynamic particle 
size distribution of the airborne particles will affect the bronchial dose. Smoke in the air 
space can have a large effect on the bronchial radiation dose from radon decay products. 
Clearly, a simple measurement of the average concentration of radon in the air is insufficient 
to provide an accurate estimate of the lifetime average radiation dose rate to the bronchial 
epithelium of a person. Many reported studies only involve average radon measurements. 
Many reported studies only reported cumulative exposures to radon decay products in 
units such as working level months (WLM).  
3.3 Lung cancer from exposure to radon and its decay products 
Uranium mining in the 20th Century led to the clear realization that protracted and repeated 
exposures to high concentrations of radon can cause lung cancer. For example, miners 
working uranium mines in the Colorado Plateau region of the USA were found to have a 
high incidence of lung cancer depending on the level of exposure. People chronically 
exposed over extended period of employment to high levels of airborne radon decay 
products such as are found in uranium mines have developed bronchogenic carcinoma at 
incidence rates that significantly exceeded the expected rates in either smokers or non-
smokers. However, almost all the lung cancer cases in the western U.S. mines occurred in 
smokers (Saccomanno et al., 1988). The reported excess relative risks of lung cancer as a 
function of cumulative dose expressed in working level months of exposure are shown in 
Figure 18. The miners did not have radon dosimeters and it could never be clear how long 
anyone worked in any of the areas within the mines, hence the working level month (WLM) 
values are estimates that are intended to represent cumulative radiation dose. As with all 
cumulative dose plots it is common to fit or draw a linear no-threshold function that begins 
at the origin obscuring the apparent virtual threshold. This is facilitated by the large 
dosimetric uncertainties (Lubin et al., 1995). 
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Fig. 18. Historical data of observed lung cancer risk as a function of exposure in working 
level months (WLM) among uranium miners from the Colorado Plateau in the United States 
(BEIR IV, 1988). Uranium miner data were routinely expressed in estimated cumulative 
doses in WLM so that the virtual threshold was badly obscured or ignored and linear no-
threshold (LNT) models were assumed to apply in every case (Figure 19).  
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Fig. 19. Observed relative risk (RR) of lung cancer in underground miners versus 
cumulative airborne radon decay product exposure in working level months (WLM) for 
WLM less than 400 with a linear no-threshold risk model fit to the data (Lubin et al., 1994). 
The reported epidemiological studies of radon in homes are not conclusive and are usually 
based on average radon concentration measurements rather than on decay product levels 
and the results were displayed using the standard linear no-threshold assumption. Also, the 
dosimetric uncertainties are usually not displayed. In Figure 20 the authors created a 
mathematical relative risk of 1 at a radon concentration exposure of zero but there is no such 
point in the real world. The major cause of lung cancer in the United States is known to be 
cigarette smoking (up to 95% incidence) so that cigarette dosimetry is actually more 
important than radon dosimetry in these types of studies. 
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Fig. 20. Summary of calculated relative lung cancer risk mathematical meta-analysis of 
indoor radon studies along with miner studies (BEIR VI, 1999). 
A careful ecological study was conducted of the relationship of lung cancer mortality as a 
function of measured air concentrations in homes in over 1,600 counties in the United States 
(Cohen, 1995). The remarkable results showed that the counties with homes having the 
higher radon concentrations tended to have the lowest lung cancer mortality rates (Figure 
21). This relation was robust and was demonstrated for widely separated counties in various 
parts of the United States. His finding were in conflict with the prevailing linear no-
threshold theory promulgated by the ICRP and United States Environmental Protection 
Agency (EPA). A scientific committee formed to review the radon risk data concluded that 
the results were faulty no matter how robust and reproducible because they were based on 
an ecological study that could not directly match cases and radon exposures (BEIR VII-2, 
2006). Cohen argued to no avail that under the LNT hypothesis the distribution of the doses 
was irrelevant and his data proved the linear no-threshold model did not apply to exposure 
to radon in homes. Although it is mathematically possible that Cohen’s ecological study is 
misleading, it seems highly unlikely that such an anomaly would uniformly appear 
everywhere in the United States. Cohen’s result is substantiated by a simple comparison of 
the County by County radon zones and lung cancer mortality rates (Figure 22). 
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Fig. 21. Lung cancer mortality rates in men versus mean radon level for 1,601 counties 
spread throughout the continental United States as a function of mean radon level with the 
abscissa in units of 37 Bq m−3 (Cohen, 1995). 
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LUNG CANCER: Blue Low, Red High ↑ 
  
↓ RADON: Red HIGH, Yellow LOW 
 
Fig. 22. Comparison of lung cancer mortality rates and radon concentration in homes among 
the counties of the United States of America. 
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A conditional logistic regression case-control study of lung cancer risk from residential 
radon was conducted in the State of Massachusetts in the United States by Thompson et al. 
(2008). Although their radon dosimetry was limited to average air concentration, they also 
evaluated cigarette smoking dose in a precise manner by stratifying the data with nine 
categories of smoking history. This ingenious approach led to results that agreed well with 
Cohen’s ecological study (Cohen 1995). They found that lung cancer rates were the highest 
in those people with the smallest radon expose levels (<25 Bq m-3). As radon levels were 
increased the lung cancer rate went down in a consistent manner which was statistically 
significant in one dose group (p<0.05 at 59-75 Bq m−3) and statistically strong in three others 
(p<0.1). Radon induced lung cancer appeared to be present only for average radon air 
concentrations greater than 250 Bq m−3.  
Fornalski and Dobrzynski (2011) reanalyzed the data from 28 published studies of the 
relationship of lung cancer and radon exposure using Bayesian statistical methods. They 
concluded that for people exposed to radon concentrations less than 838 Bq m−3 in those 28 
studies there is no evidence that there is an association between radon exposure and lung 
cancer incidence. 
These studies suggest that radon exposures at low dose levels can interfere with ongoing 
neoplastic processes in the lung as may be associated with cigarette smoking. Mechanisms 
such as stimulation of DNA repair may be invoked by low level exposures to ionizing 
radiation helping to inhibit the damage associated with chemical carcinogens such as 
cigarette smoke exposures. Similarly, up-regulating and down-regulating of genes at lower 
ionizing radiation doses can interfere with ongoing carcinogenic biological processes and 
lead to reduced cancer development.  
4. External ionizing radiation epidemiology  
4.1 Typical study problems 
Several external ionizing radiation epidemiology studies have been conducted. However, 
some of these studies involve technical problems that affect the reliability of the findings. A 
distortion of the possible carcinogenic response is associated with the use of cumulative 
dose as the radiation exposure measure rather than the more appropriate lifetime average 
dose rate. Several confounders such as exposure to toxic and carcinogenic chemicals are 
quite difficult to properly evaluate and are often ignored. In years past two carcinogenic 
agents, benzene and trichloroethylene, were commonly used as cleaning agents in 
laboratories including nuclear research laboratories. There were few if any records of these 
exposures or chemical doses. The most important confounder among the predominantly 
male radiation workers is cigarette smoking. Confounding occurs when the workers who 
are most likely to receive the highest exposures to ionizing radiation are also the most likely 
to have been smokers. It is possible that those workers at nuclear facilities (mostly men) who 
worked most directly in the radiation areas were more predominantly cigarette smokers 
than workers who had managerial, supervisory, or clerical assignments. This confounding 
from smoking is most likely important prior to 1960 before the health risks of smoking were 
well understood. This possibility is most prominent in studies of workers at Oak Ridge 
National Laboratory in the United States State of Tennessee where nuclear operations began 
in 1943. Some epidemiological studies of Oak Ridge workers have attributed lung cancer 
and other smoking-related illnesses to radiation exposure (Wing et al., 1991).  
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4.2 Atomic worker studies 
Two major series and the most important are the ionizing radiation epidemiological studies 
of multinational radiation works in several countries of the world that have been conducted 
by Cardis and her numerous co-workers (Cardis et al. 1995, Cardis et al. 2005). The two 
studies were similar in approach, but the second was much larger and included subjects 
who were in the first study. In these studies emphasis was on workers who had available 
ionizing radiation dosimetry records of external photon exposure (x rays and gamma rays) 
but who did not have major internal exposure or neutron exposure. In the second study 
internally deposited radionuclide dose was specifically limited to ten percent of the total. 
Two cause of death risk types were separately evaluated: (a) leukemia excluding chronic 
lymphocytic leukemia and (b) all cancers excluding leukemia. Simple linear dose-response 
models of risk that was assumed to be proportional to cumulative external ionizing 
radiation dose were statistically evaluated. Radiation doses were lagged by 10 years for 
cancer cases and 2 years for leukemia. Hence, they assumed the cancer risk was 
proportional to the cumulative dose received prior to the lag period just before death. 
If a person developed lung cancer, the radiation dose received in the prior 10 years was 
assumed to have not been a contributor to the risk. Typical lifetime doses in these studies 
were well below 1 Sv, so that the risk of radiation-induced cancer would be expected to be 
very near zero, based on the internal emitter studies discussed above. 
In the first study (Cardis et al., 1994; Cardis et al., 1995) 95,673 nuclear industry workers 
(85.4% men) in the United States, United Kingdom, and Canada were monitored for external 
exposure to ionizing radiation prior to 1988. A linear cumulative dose response model with 
Poisson regression was used to estimate excess relative risk per Sv. Eleven dose categories 
were used. Also, it was assumed that radiation might increase cancer risk but it would not 
decrease cancer risk, so a one-tailed statistical test was used with significance at the 10% 
level instead of the usual 5% level. In this study about 99% of the deaths involved lagged 
doses less than 0.4 Sv. No evidence of association was found between radiation dose and 
mortality from all causes or from all cancers. However, mortality from leukemia, other than 
chronic lymphocytic leukemia, had a statistically significant association in a trend test with 
cumulative external radiation dose (estimated p=0.046, 119 deaths among 15,825 deaths). 
This estimated trend test p=0.046 is primarily based on 6 cases among 238 deaths above 400 
mSv which by itself is not significant. The excess relative risk for leukemia excluding chronic 
lymphocytic leukemia was reported to be 2.18 per Sv (90% confidence interval 0.1 to 0.99). 
The excess relative risk for all cancer types excluding leukemia was minus 0.07 per Sv (90% 
confidence interval minus 0.4 to 0.3). These results may be somewhat affected by the use 
cumulative dose risk mathematical models rather than the more appropriate lifetime 
average dose rate models. Exposures to leukemia-causing organic chemicals may have 
occurred in the workplace. 
In the second enlarged study (Cardis et al. 2005) 407,391 nuclear industry workers (90% 
men) in 15 countries who had available external exposure ionizing radiation dosimetry data 
were evaluated by a joint analysis group with 50 contributors. These 15 countries included 
Australia, Belgium, Canada, Finland, France, Hungary, Japan, South Korea, Lithuania, 
Slovak Republic, Spain, Sweden, Switzerland, United Kingdom, and the United States. 
Organ doses were estimated by dividing the recorded doses by organ dose bias factors. The 
colon and bone marrow doses were used for both all cancers excluding leukemia and for 
leukemia. Eleven dose groups were created. Analyses used a simple linear relative risk 
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Poisson regression model of the form where relative risk equals 1+ǃZ where Z is the 
cumulative equivalent dose in Sv; 95% likelihood based confidence intervals were 
calculated. Estimates of excess relative risk were stratified for sex, age, and calendar period, 
facility, duration of employment, and socio-economic status. A total of 24,158 (5.9%) died 
during the study period including 6,519 from cancer other than leukemia and 196 from 
leukemia other than chronic lymphocytic leukemia. The leukemia incidence was statistically 
limited and the risk per Sv was not significantly different from zero.  
The key results of this second study for cancer other than leukemia (Cardis et al. 2005) are 
summarized in Fig. 23. None of the cohorts were found to have excess relative risk of cancer 
other than those in Canada. The overall combined excess relative risk per sievert for all 
cancer excluding leukemia was 0.97 (0.14 to 1.97 ninety-five percent confidence range). The 
excess relative risk per sievert for all cohorts for non-leukemia cancers excluding lung and 
pleural cancers, which may be related to smoking, was no longer significantly different from 
zero [0.59 (-0.29 to 1.70 ninety-five percent confidence range)]. Of the fifteen countries, the 
calculated excess relative risk of cancer that was observed in Canada appear to be 
anomalously high for some unknown reason. When the study analyzed only the other 14 
countries the excess relative risk of cancer (other than leukemia) per sievert was no longer 
significantly different from zero [0.58 (-0.22 to 1.55 ninety-five percent confidence range)]. 
With this abridgement, there would be no significant cancer risks observed in this study. 
 
 
Fig. 23. Excess relative risk per Sv for all cancer types except leukemia in cohorts with more 
then 100 deaths in radiation worker study of 15 countries; NPP = nuclear power plants, 
ORNL = Oak Ridge National Laboratory in Tennessee, and Hanford = the Hanford 
Laboratory in Richland, Washington (Cardis et al., 2005). 
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5. Nuclear power plant accidents 
5.1 Three Mile Island 
The accident at the Three Mile Island in Dauphin County, Pennsylvania, USA, on March 28, 
1979, drew attention to the possible exposures of people to radionuclides that might be 
released from a nuclear power during an accident involving the overheating of the nuclear 
fuel. Because of the design issue and instrument confusion, the plant operator of the Unit 2 
reactor was led to think that the cooling water level was high when in fact it was low. 
Eventually, feed water pumps failed and the reactor overheated. Steam and water were 
vented through a relief valve and the reactor control rods scrammed in and the reactor shut 
down. Even though the fission chain-reaction process had been terminated, the heat 
generated by the highly radioactive fission decay products overheated and melted part of 
fuel elements and their containment tubes. Volatile radionuclides such as 131I and 137Cs were 
released from the reactor containment but because of high efficiency particle filters and 
activated charcoal filters, very little was released to the outdoors. The extent of the risk to 
people living near the reactor was not clear as the accident progressed. Fortunately, no 
member of the public received a serious exposure. The maximum total radiation exposure to 
the members of the public was estimated to be only a few μSv from small releases of 
radioiodine, 131I. The Unit 2 nuclear reactor unit was damaged beyond repair. The twin 
Three Mile Island Unit 1 nuclear reactor is still operational. 
5.2 Chernobyl 
An extremely serious and catastrophic Chernobyl nuclear reactor accident in the Ukraine 
occurred on 26 April 1986 when a nuclear reactor number four went super-critical during a 
systems test of the control rods. This reactor did not have a strong containment building and 
used graphite carbon for a neutron moderator. The resulting super-critical reaction 
destroyed the fuel elements, ruptured the reactor vessel, and exposed the graphite 
moderator which, with exposure to air, began to burn. The seriously damaged containment 
allowed the resulting smoke and effluent of radionuclides to mix with the outdoor 
atmosphere and spread fallout over much of the Ukraine, Soviet Union, and other parts of 
Europe. Not only did the most volatile radionuclides such and 131I and 137Cs escape but also 
many other fission product radionuclides such as 90Sr and 144Ce were part of this 
widespread airborne contamination. Twenty-six power plant workers died of acute whole 
body radiation overdoses. 
The large population exposure to long-term protracted ionizing radiation associated with 
the 1986 Chernobyl reactor accident in the Ukraine was predicted with the linear no-
threshold model to result in a virtual epidemic of long term radiation-induced cancer 
(Anspaugh et al. 1988). Instead, there was no apparent major health effects of this 
widespread protracted exposure to ionizing radiation except for thyroid disease associated 
with very high acute radiation doses from short-lived (half life 8 days) radioiodine (131I) 
contamination in cow’s milk and dairy products (WHO 2006, Jaworowski 2010). 
5.3 Fukushima Daiichi  
Three of the six boiling water nuclear power plants at Okuma, Fukushima, Japan, 
underwent destructive meltdown of the nuclear fuel along with widespread releases of 
radioactive fission products to the environment as a result of massive flooding associated 
with the Tohoku earthquake and tsunami on March 11, 2011. Although plants safely shut 
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during the earthquake, the tsunami that followed completely flooded the plants and shut 
down all sources of local and nearby electricity. Without electricity it was not possible to 
operate water pumps needed to cool the reactor fuel to prevent overheating associated with 
the natural radioactive decay of fission product radionuclides produced during normal 
operations.  
When the quake occurred units 1, 2, and 3 were operational, but unit 4 had previously been 
defueled and units 5 and 6 had been shut down for maintenance. Ultimately the fuel elements 
in units 1,2, and 3, overheated and ruptured, The special zircaloy cladding reacted with steam 
to produce large quantities hydrogen gas which vented into the containment buildings and 
subsequently exploded injuring workers and damaging the building walls and roofs. 
Ultimately, there were widespread releases to the outdoor air of smoke and volatile fission 
products from the damaged nuclear fuel. These releases lofted into the atmosphere and 
were diluted and carried for long distances. The most important human exposures were 
probably those associated with contamination of water and food. Two most prominent 
fission products released in this accident were short-lived (half life 8 days) radioiodine (131I) 
and long-lived (half life 30 years) radiocesium (137Cs). Both of these radionuclides are beta 
radiation emitters that can efficiently irradiate body organs if inhaled or ingested. 
Associated gamma rays contribute a more diffuse and less important portion of organ doses 
when these radionuclides are internally deposited in the body of a person.  
Ingested 131I primarily follows the grass to cow to milk route of human exposure. Ingested 
iodine tends to concentrate in the small thyroid gland where it can efficiently irradiate the 
thyroid tissue. The very efficient release of iodine from damaged nuclear fuel and the short 
radioactive half life of 131I means that the risk of exposure is relatively short-lived after an 
accidental release but the acute doses to the thyroid gland can be quite large. From studies 
of children who ingested 131I from the Chernobyl nuclear reactor accident, it has be observed 
that the risk of thyroid cancer is primarily associated with thyroid cumulative radiation 
doses larger than about 10 Sv.  
Ingestion or inhalation of 137Cs leads to very uniformly widespread irradiation of body 
because cesium is quite soluble in most of its chemical forms and behaves somewhat like 
potassium in the human body. Although 137Cs has a long physical half-life, it has a relatively 
short biological half life on the order of about one month. For an acute single intake, very 
little remains in the human body after one year. In the environment, cesium tends to 
strongly bind by ion-exchange with clay in soils, somewhat limiting its uptake into plants. 
In order to evaluate the biological risk, including carcinogenesis, associated with the intake 
of 137Cs, fifty-four beagles were injected with graded dosages of 137Cs as cesium chloride 
from 32.5 to 148 MBq per kg body weight and held for lifetime study at the Inhalation 
Toxicology Research Institute (Mauderly and Daynes, 1989)(Fig. 24). Because of the 
relatively short biological retention half-time of about 30 days (Boecker, 1969), about half of 
the whole body absorbed dose from 137Cs beta rays and 137mBa daughter gamma rays was 
delivered in the first 30 days after the injection and nearly all of the dose was delivered 
within one year. Those deaths that occurred prior to one-half year after injection were 
associated with direct injury to the blood forming organs by beagles receiving the highest 
dosages of 137Cs. There were only 12 unexposed controls assigned to this study, but the fate 
of 52 other controls assigned to contemporaneous studies was used for comparison to the 
exposed dogs. Those beagles that survived the acute injury phase in the very highest dose 
groups lived about as long as unexposed controls and had insufficient cases of radiation 
induced cancer to develop a meaningful three-dimensional model.  
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Fig. 24. Distribution of deaths in lifetime studies of beagles injected with 137CsCl at ITRI 
(Raabe,1994). 
A Peto trend test (Peto et al, 1980) of the cancer cases showed that two cancer types had a 
statistically significant occurrence: (a) nasal carcinomas reported in 4 exposed dogs and not 
observed in controls, and (b) hemangiosarcoma in different organs (4 cases) with one case in 
controls. The lowest lifetime cumulative whole body radiation dose associated with a death 
with nasal carcinoma was 7.7 Gy; this compares with the lowest skeletal beta radiation dose 
of 18.4 Gy associated with the occurrence of nasal carcinoma in beagles exposed to 90Sr at 
Davis. There was no statistically significant incidence of lung, liver, or bone cancer, and no 
reported cases of leukemia. This result is consistent with the expected risk of radiation-
induced cancer from protracted exposure as discussed above. 
6. Summary of protracted and repeated exposure cancer induction risk 
As presented in the previous sections, the studies of repeated and protracted exposures to 
ionizing radiation have shown that radiation induced cancer follows a sharply non-linear 
upward temporal pattern with a virtual threshold at lower life-time average dose rates 
(Raabe, 2010). The precision and time-delay of the cancer induction phenomenon indicate an 
underlying gradual biological process involving many altered cells associated with cellular 
deoxyribonucleic acid (DNA) mutations, clonal development depending on cell division 
cycles, cellular maturation, and average ionizing radiation dose rate over long latency 
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periods. Studies described above of protracted exposures to ionizing radiation from 
internally deposited radionuclides in people and laboratory animals have demonstrated that 
cancer induction risk is actually a somewhat precise function of average dose-rate and that 
at lower average dose rates cancer latency can exceed natural life-span. 
Because of the long latency at low dose rate that may exceed the natural life-span, the 
radiation-induced cancer risk associated with protracted exposures to ionizing radiation 
involves a life-span virtual threshold when the lifetime average dose rate is low and the 
cumulative dose to sensitive tissues is below about 10 Sv.  
Life-span virtual thresholds for radiation-induced cancer risk should exist for other types of 
protracted and fractionated exposures including radon inhalation and external exposures 
associated with background levels of ionizing radiation from environmental radionuclides. 
The organs, tissues, and cells of the body cannot distinguish between ionizing radiation 
emitted by internally deposited radionuclides or entering the body from external sources. 
Low linear energy transfer (LET) gamma rays from external sources yield ionizing energetic 
electrons in the body and beta particles from internally deposited radionuclides are also 
ionizing energetic electrons. High LET neutrons from external sources yield ionizing 
energetic protons whose radiation quality weighting factors are similar to high LET ionizing 
alpha particles from internally deposited radionuclides (Raabe, 2011). 
Another important finding is that two beta particles are about equal on the average to one 
alpha particle in the radiation induction process (Raabe 2010). This finding suggests that 
double strand damage to cellular DNA is involved in the cancer induction process. While 
one alpha particle hitting DNA may produce the necessary double-strand break, two beta 
particles almost simultaneously hitting the DNA are apparently needed to produce similar 
double-stand breaks. Also, the shape of the cancer-induction dose-response curve is not 
linear but rather sharply increasing as a function of cumulative dose delivered from 
virtually zero risk at low doses to high risk at high doses as a function of dose rate. 
7. Single acute exposures to ionizing radiation 
7.1 Atomic bomb survivor studies 
A quite different phenomenon has been observed in studies of the Japanese survivors of 
atomic bombs detonated over Hiroshima, August 6, 1945, and over Nagasaki, August 9, 
1945 (Manhattan Engineer District 1946). These Japanese survivors were exposed 
instantaneously to a large acute pulse of external gamma radiation (and some neutrons) 
delivered in about one minute. Many of these acute absorbed doses were several hundred 
times the normal annual radiation exposure from background radiation. All of the cells of 
the body were exposed to this large ionizing radiation pulse and those cells and body tissues 
were all affected in some way. Years later some of the highly exposed survivors developed 
cancer of the same types as occurred in the control population but somewhat earlier and at 
somewhat higher rates. In addition, the increases in these cancer cases were proportional to 
that one-minute whole-body absorbed radiation dose. This linear relationship is in sharp 
contrast with cancer induction observed in the protracted and repeated exposures described 
above. Except for some early cases of myeloid leukemia caused by acute radiation damage 
to the blood forming tissues of the body from the higher exposures, there were no apparent 
radiation induced cancer cases among the atomic bomb survivors (Raabe, 2011). 
There has been a long-standing scientific disagreement concerning cancer induction 
associated with protracted and repeated exposures to ionizing radiation and the 
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carcinogenic effects of the atomic bomb acute instantaneous exposures. The reason for this 
conflict is readily apparent from the data themselves. It is explained by the fact that the 
increased risk of cancer observed in the atomic bomb survivor studies was primarily the 
result of acute high dose-rate promotion of ongoing biological processes that lead to cancer 
in the Japanese people rather than actual de-novo cancer induction.  
The Japanese survivor studies are very important since they have been extremely well done 
and represent a significant body of human data about the possible effects of acute exposure 
to ionizing radiation (RERF, 2008). Also, the currently accepted methodology for estimation 
of solid cancer risk associated with human exposure to ionizing radiation is based primarily 
on the detailed studies of the Japanese atomic-bomb survivors (ICRP-26, 1977; ICRP-60, 
1991; BEIR VII Phase 2, 2006; NCRP 136, 2001; ICRP 103, 2007). The prevailing models of 
human ionizing radiation exposure risk and relative organ sensitivities (ICRP tissue 
weighting factors, WT) are based primarily on those studies. Specifically, the concept that 
cancer risk as a linear function of cumulative dose and follows a linear no-threshold cancer 
risk model is based primarily on the acute high dose rate exposures received by the 
Japanese atomic bomb survivors. 
7.2 Radiation promoted cancer from acute exposures 
The Radiation Effects Research Foundation (RERF) and its predecessor Atomic Bomb 
Casualty Commission (ABCC) studied the development of solid malignant tumors in about 
80,000 of the Japanese atomic bomb survivors (Pierce and Preston, 2000; Preston et al., 2003; 
Preston et al., 2004; Preston et al., 2007). The main study considered 79,972 survivors for 
which there were available calculated radiation doses. Of these, 44,636 survivors had 
calculated doses that exceeded 5 mSv. Those with less than 5 mSv doses were used as the 
control group (Preston et al., 2007). These about one-minute acute exposures involved very 
high-energy gamma radiation and some neutrons. Myeloid leukemia from high dose bone 
marrow exposures followed a different response course and is usually considered separately 
from the solid tumor incidence.  
The traditional approach is to assume that the solid malignant tumors are the result of 
simple stochastic (isolated and random) initiating events in individual cells that occurred 
during that about one-minute exposure. This simplistic stochastic model of ionizing-
radiation-induced cancer is based on the idea that a single cell is randomly altered by a 
unique ionizing radiation event causing a unique pre-malignant mutation in that cellular 
deoxyribonucleic acid [DNA] (Moolgavkar et al. 1988; Heidenreich et al. 1997). This single 
random event then ultimately leads to a clone of similar pre-malignant cells. Later, usually 
much later, a second random DNA alteration occurs in one of the clonal pre-malignant cells 
that produces a malignant cell that develops into a monoclonal malignant tumor. This 
process began with the single random (stochastic) cellular event. This process can be 
advanced by promoter agents including other ionizing radiation that presumably affect the 
clonal development, quantity, and maturation of the pre-malignant clonal cells (Heidenreich 
et al., 2007) . A cancer promoter is anything that advances the development of a malignancy 
other than a directly carcinogenic agent or an intrinsic component of the carcinogenesis 
process (Casarett, 1968). Mathematical models are readily constructed with unknown 
parameters and hypothetical modifying factors and process lag times designed to fit the 
data associated with acute ionizing radiation exposures (Heidenreich et al., 1997). 
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The internal emitter studies discussed above strongly suggest that double strand DNA 
damage or a related phenomenon is involved in the cancer induction process associated 
with ionizing radiation. In particular, two low LET beta particles were found to be required 
to match the radiation induction process associated with each alpha particle (Raabe 2010). 
Since the exposure of the Japanese atomic bomb survivors was primarily associated with 
low LET gamma radiation and associated energetic electrons, two hits at the same region of 
DNA in a target cell would be expected to be required for the induction of cancer. The 
resulting increase in cancer by induction in this two-hit process would follow a sharply 
increasing curvilinear power function of increasing cumulative absorbed dose. In fact, the 
increase in cancer among the atomic bomb survivors tended to follow a remarkably linear 
pattern as a function of absorbed ionizing radiation dose. Deterministic cancer promotion of 
those types found in the exposed population rather than simple isolated stochastic cancer 
induction better explains the increase of solid cancers in the atomic bomb survivor studies. 
 
 
Fig. 25. Linear dose-response relationship of Excess Relative Risk for the promotion of solid 
cancer in Japanese survivors of the atomic bomb detonations at Hiroshima and Nagasaki in 
1945 with respect to survivors who received low radiation exposures as reported by the 
Radiation Effects Research Foundation [RERF](Preston et al. 2007). 
The studies of the atomic bomb survivors demonstrate a linear dose-response promotional 
effect related to the natural or existing biological processes that may eventually lead to 
cancer in the exposed population (Fig. 25). These processes involve years of cellular 
division, clonal expansion, and cellular maturation. The exposure to a sudden high dose of 
ionizing radiation delivered in about one minute at the time of the nuclear detonations may 
have advanced or stimulated the cellular changes that eventually lead to various typical 
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types of cancer. Hence, some cancers may have appeared at an earlier time than otherwise 
would have occurred based on the existing underlying cellular and tissue processes (Fig. 
26). This promotional effect was observed to advance cancer rates not only relatively soon 
after exposure but throughout the lives of the exposed individuals (Fig. 27). This behavior is 
proportional to the instantaneous dose just as would be expected for any phenomenon that 
involves augmentation of existing processes rather than a few random or “stochastic” 
changes in a few select cells.  
 
 
Fig. 26. Observed Excess Relative Risk by body organ for promoted solid cancer observed 
for one Sv of equivalent ionizing radiation dose in highly irradiated Japanese atomic bomb 
survivors compared to survivors who received low radiation exposure as reported by the 
Radiation Effects Research Foundation [RERF] (Preston et al. 2003). 
Concerning the solid tumor incidence in the atomic bomb survivor studies, Pierce and 
Mendelsohn (1999) pose the question, “How could it be that the excess cancer rate might 
depend only on age and not on time since exposure or age at exposure?” Fig. 27 shows that 
the increase in malignant solid tumors in the atomic bomb survivors associated with their 
radiation exposure follows the same lifetime pattern irrespective of the age at exposure. The 
simple answer is that the normal progression of cancer incidence in the population was 
somewhat promoted by the radiation exposure without the actual independent induction of 
cancer. This promotion is not a single event stochastic process but rather the result of the 
almost instantaneous delivery of ionizing charged electrons produced in all the tissues by 
ionizing radiation from the atomic bombs. The tissues response is complex and unfocused. 
The cells of the tissue communicate among themselves as a result of the exposure in a 
process called bystander effect with various responses evoked even among the cells in these 
tissues that were not directly impacted (Hall 2003). Tissues respond to sudden ionizing 
radiation exposure with up-regulation of various genes and down-regulation of others 
(Snyder and Morgan, 2004; Coleman et al. 2005). This imprint is apparently not lost and 
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carries forward throughout life promoting the existing biological processes that may lead to 
cancer in the exposed atomic bomb survivor population. This complex process suggests a 
systems biology phenomenon rather than a unique stochastic response (Barcellos-Hoff, 
2008). 
 
 
Fig. 27. Observed gender-averaged age-specific excess incidence rates at 1 Sv for most major 
solid cancers over the 1958-1987 follow-up period for ages at exposure 10 y, 30 y, and 50 for 
the Japanese atomic bomb survivors (Pierce and Mendelsohn, 1999). The excess rates appear 
to depend only on age and not on time since exposure or age at exposure as might be 
expected for radiation-induced promotion of the cancer types normally found in this 
population. 
The Japanese atomic bomb survivor data are unique because they do not in any way predict 
the observed carcinogenesis associated with protracted exposures as occur in the case of 
internal emitters. In fact, the acute gamma ray exposures clearly represent a completely 
different mechanism of carcinogenesis from that which occurs with protracted exposure as 
with long-lived internal emitters (Raabe 2011). The resulting cancer promotion phenomena 
in the atomic bomb survivors should not be expected to describe the effects of similar 
exposures delivered uniformly or fractionated over a relatively long period of time. Since 
promotion is a relative process rather than an absolute process, it is not meaningful to try to 
create absolute risk estimates from relative response information. 
The tissue-weighting factors (wT) developed by the ICRP to calculate the so-called effective 
dose are actually a reflection of the convolution of the underlying incidences of different 
types of cancer in the control population and the relative promotional effect of the whole 
body exposure to gamma rays and some neutrons in the Japanese atomic bomb life-span 
studies (ICRP 26, 1977; ICRP 30, 1979; ICRP 60, 1991; ICRP 103, 2007). Cancers that were 
somewhat rare in this Japanese population, such as bone cancer, were assigned relatively 
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low tissue weighting factors relative to the whole body cancer or assumed genetic risk (such 
as wT = 0.01 for bone surfaces). Cancers that were somewhat common in this Japanese 
population, such as lung cancer, were assigned relatively high ratio values relative to the 
whole body cancer or genetic risk (such as wT = 0.12 for whole lung) . These tissue-
weighting factors (wT) can be related to observed cancer promotion, but are unrelated to the 
cancer induction associated with protracted or fractionated exposure to ionizing radiation. 
The use of tissue-weighting factors (wT) recommended by the ICRP based on the atomic 
bomb survivor studies is inappropriate for protracted or fractionated exposures. 
The elaborate Radiation Effects Research Foundation (RERF) studies of the atomic bomb 
survivors have investigated in rigorous detail the effect of whole body irradiation by high-
energy gamma rays (and some neutrons) delivered in about one minute. The A-bomb RERF 
life-span study clearly describes a meaningful linear dose model of promotion of ongoing 
biological processes that lead to increased cancer rates for brief high dose rate exposure to 
ionizing radiation. The relative risk values might be applicable to other brief high dose-rate 
ionizing radiation exposures as may occur in occupational exposures or in medical 
diagnosis and treatment (Hall and Brenner, 2008). However, there is still considerable 
uncertainty for acute doses less than about 0.05 Sv. Small acute doses may by beneficial as 
they may promote or stimulate DNA repair or other defensive cellular phenomena that 
reduce promotional cancer risks associated with ongoing cellular processes that might 
otherwise lead to cancer (Feinendegen 2005).  
7.3 Acute medical exposures 
7.3.1 Medical exposure concerns 
Among the most common instantaneous exposures of people to ionizing radiation are those 
associated with diagnostic medical radiographs (X-rays). Modern computed tomography 
(CT) scans using x rays with higher radiation doses can provide precise three-dimensional 
images and are of great medical value. Fluoroscopic images that use nearly continuous 
irradiation are also valuable in certain medical procedures. The question as to whether these 
acute diagnostic medical exposures result in an increased cancer risk has been considered 
and even assumed in various studies. The promotion of cancer observed among the 
Japanese atomic bomb survivors is a reasonable basis for considering the possible cancer 
promotion associated with medical exposures to ionizing radiation, but protracted 
exposures do not seem to involve cancer risk at small doses and sometimes appear 
beneficial.  
7.3.2 Neonatal medical exposures 
Among the earliest studies of possible effects of medical exposures of patients associated 
with diagnostic X-rays are those associated with the Oxford Survey of Childhood Cancer 
(OSCC) of deaths in England, Wales, and Scotland from childhood cancer. These case-
control studies were initiated and advanced by Alice Stewart, a British physician (Stewart et 
al., 1956; Stewart et al., 1958). The basic hypothesis of these studies is that childhood cancer 
was caused in part by fetal exposures from medical X-rays associated with diagnostic 
radiology of the pregnant mothers. Healthy control children were matched by sex, by birth 
location and, as closely as readily possible, by birth date. A comprehensive summary and 
statistical evaluation has been published (Mole 1990). The overall study considered a 
majority of the cancer deaths in of children in Britian under the age of 16 primarily spanning 
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the years 1953 to 1978. Most of the major findings were based on children who were born 
between 1940 and 1969. The initial studies inquired from the mothers about X-ray films that 
might have been made during pregnancy. Later studies involved verification by review of 
medical records, but not all cases could be verified. There was no direct ionizing radiation 
dosimetry associated with these studies. Overall, there was a strong trend to a higher 
fraction of diagnostic radiology among the mothers of children who died of cancer 
compared to the healthy controls. Typical overall raw values of these ratios were 1.33 for 
children dying under age 6, 1.38 for children age 6 or older dying under age 10, and 1.27 for 
children age 10 or older dying under age 16. For births that occurred prior to 1957 the odds 
ratios were significantly above unity, while for later births they were not. It may have been 
most difficult to verify the X-ray recollections of the mothers for those earlier years. The 
odds ratios for X-raying in Britian for the four birth years 1958 to 1961 were 1.27. 1.36 
and`1.02 for cancer deaths at ages 0 to 5, 6 to 9, and 10 to15, respectively. The overall odds 
ratio for all ages 0 to 15 years was 1.23 with a 95% confidence interval from 1.04 to 1.48 and 
the associated excess lethal tumor rate from in utero x ray exposure was 0.00028 with a 
confidence interval from 0.48 to 0.00058 (Mole. 1990). 
The findings from the Oxford Survey of Childhood Cancer tend to show an important trend, 
but they may not convincingly prove that in utero X-rays were the cause of childhood 
cancer. Much of the earlier data were based on patient-reported X-ray exposures. A mother 
whose child died of cancer is more likely to remember or readily believe that she received X-
ray exposures than a mother of a healthy child. Early medical records may have been 
incomplete or difficult to locate. 
In many cases the X-rays may have been associated with some medical complication or 
abnormality associated with the pregnancy especially in many cases where the mother was 
X-rayed more than once. Those medical abnormalities, if they existed, may have directly 
contributed to later development of cancer in the child. Another possibility is that the in 
utero exposure promoted a pre-cancer process that led to earlier cancer development than 
would have otherwise occurred, but the low radiation doses involved in these studies was 
too low to correlate with the atomic bomb survivor studies promotional effects (Preston et 
al., 2007). Totter and McPherson (1981) point out that differences in population groups in 
the Oxford Survey and other factors can explain for the observed relationships. 
Although no dosimetry was available to accurately estimate the maternal or in utero 
ionizing radiation doses associated with the X-ray exposures in these studies, Mole (1990) 
attempted to estimate the risk of childhood cancer per unit of absorbed ionizing radiation to 
the fetus using estimates made in 1966 by the Adrian Committee of the British Ministry of 
Health. He assumed that average dose from all obstetric radiography was 0.61 cGy. From 
his calculated excess lethal tumor rate he calculated and reported a risk coefficient for 
irradiation in the third trimester for childhood cancer deaths at ages up to 15 years equal to 
0.00046 per cGy with a confidence interval from 0.8 to 0.00095 per cGy. This estimate is not 
valid because the Oxford Survey of Childhood Cancer does not provide any dose-response 
information for anyone in the study nor for the whole population at risk. More than 95% of 
the cases of childhood cancer are not explained by neonatal radiography. In 1958 there were 
840,196 births in Britian and it was likely that at least 100,000 babies were irradiated in utero 
based on the estimates (Mole 1990). The number of deaths associated with cancer ages 0-14 
born in 1958 was 977 and the data show that about 15% of those or about 150 had been 
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irradiated in utero. Therefore the fraction of those irradiated that died of cancer in childhood 
was about 0.15%. 
It might be noted, however, that the promotion of cancer observed in the atomic bomb 
survivor studies is a mechanism that could explain the observed results, but there are no 
statistically significant radiation promoted cancer risks for acute doses below about 10 cSv 
among the atomic bomb survivor data. (Preston et al. 2007). Totter and McPherson (1981) 
point out that differences in population groups can account for the observed misleading 
relationships since the sub-population of cancer cases does not have the same probability of 
being X-rayed as the sub-population of controls. 
7.3.3 Medical diagnostic X-ray risks 
Medical diagnostic radiology has become one of the highest sources of exposure to ionizing 
radiation in many countries of the world. This is largely associated with the increasing use 
of computed tomography (CT) images using x rays which involve much higher radiation 
doses than conventional X-ray images. Since these doses are delivered almost 
instantaneously, they can be expected to present similar cancer promotion risks as observed 
in the atomic bomb survivor studies discussed above. However, the radiation doses 
involved in the use of CT examination are typically well below the approximately 10 cSv 
dose above which the cancer promotion risk is statistically significant in the Japanese atomic 
bomb survivor studies (Preston et al 2007). Hence, attempt to extrapolate the cancer 
promotion risk associated with these small doses involves considerable imprecision and 
uncertainty. No one can be sure that the same linear no-threshold model applies precisely to 
individual organ exposures in radiology as applies to whole body exposures as occurred for 
the Japanese atomic bomb survivors. In addition, biological processes that affect the 
behavior of cells and tissues at lower doses may alter or cancel the promotional phenomena. 
For example, low acute doses may stimulate cellular DNA repair mechanisms.  
Some investigators have created somewhat precise models of what may be occurring at low 
doses to predict lifetime cancer risks from the acute x ray exposures that may be associated 
with diagnostic radiology using linear no-threshold models based on the atomic bomb 
survivor studies of cancer promotion. These studies of diagnostic medical exposure to 
ionizing radiation usually refer to their studies as estimates of risk of radiation induced 
cancer, but in this chapter the acute exposure dose phenomenon has been be more correctly 
shown to be cancer promotion. In addition, some of these studies report their results as 
cancer risks, but they are not measured risks but calculated estimates subject to the 
theoretical use of the linear model and the approximate parameters of that model obtained 
from the atomic bomb survivor studies. 
Brenner and associates (Brenner et al., 2000; Brenner, 2002; Brenner and Hall, 2007; Hall and 
Brenner, 2008) have published a series of papers providing estimates of lifetime fatal cancer 
as a function of dose from CT scans of various organs of the body as a function of exposure 
age utilizing data from the atomic bomb survivor studies and the risk models developed 
from those data by the United States National Research Council (BEIR V, 1990) and the 
International Commission on Radiological Protection (ICRP-60, 1991). 
The calculated cancer risk depends on the organ irradiated and the sex and age of the 
irradiated person. The calculated overall lifetime attributable risk tends to be higher for 
children than for adults since children have many more years of life during which cancer 
might develop. Representative values for lifetime attributable risk in these studies are from 
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0.14% for babies to 0.02% for adults. These are typical calculated values using linear no-
threshold models following from the separate organ exposure results at high doses from the 
atomic bomb survivor studies. 
Based on BEIR V (1990), Brenner et al. (2000) summarizes observed relative increased risk of 
cancer for an exposure of Japanese atomic bomb survivors exposed to one Gy for males as a 
function of age at exposure (Fig. 28). This representation clearly shows cancer promotion. 
The total risk per year is about the same for everyone. Given an 85 year life span in this 
figure, the risk per year of life for a five year old boy is about 13% over 80 years = 0.16% per 
year. For a 25 year old man the risk per year of life if about 9.5% over 60 years = 0.16% per 
year. For a 45 year old man the risk per year of life if about 6.5% over 40 years = 0.16% per 
year. The total cancer risk per year is almost independent of age at exposure. This is not 
explained by any simple stochastic cancer induction model, but is explained by some sort of 
deterministic cellular reprogramming that promotes the cancer process in a somewhat linear 
way. 
 
 
Fig. 28. Lifetime attributable cancer mortality risks for males by cancer type as a function of 
age at a single acute exposure of one Gy of Ǆ radiation based on BEIR V (Brenner et al., 
2000). 
Addition evidence for promotion is seen in the lung cancer rates shown in Figure 28. Lung 
cancer in these males may be related to smoking history. For young boys up to age 15 there 
is no apparent promotion of lung cancer (total lifetime risk about 0.5%). For these non-
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smokers there was no ongoing lung cancer development to promote. But lung cancer risk 
per year climbs for older males many of whom are likely to have been smokers with a peak 
risk at age 55.  
Berrington de Gonzalez and Darby (2004) estimated the hypothetical overall population 
cancer risks from diagnostic X-rays in the UK and 14 other countries based on frequency of 
diagnostic X-ray use, doses to different body organs, and linear no-threshold risk models 
based on the Japanese atomic bomb survival data. Their results led them to report that the 
cumulative risk of cancer for people up to age 75 from diagnostic X-ray exposures was 
indicated to be in the range from 0.6% to 1.8%.  
In studies of 64,172 tuberculosis patients of whom 39% were exposed externally to highly 
fractionated x ray chest fluoroscopies, lung cancer deaths showed no evidence of cancer risk 
associated with the x ray exposures with the relative risk at a cumulative doses of 1 Sv being 
1.00 [95% confidence interval 0.94-1.07] (Howe 1995). Also, studies of people exposed to 
unusually high levels of protracted external ionizing radiation associated with natural 
background (up to 260 mSv y−1) have not detected increased cancer risks (Ghiass et al., 
2002). 
Overall, the attributable risk values estimated in these reports from individual X-rays and 
CT scans are hypothetical and unproved since the doses involved are much smaller than 
those for which statistically significant elevations in cancer rates have been observed in the 
atomic bomb survivors. The calculations depend on the unproved assumption that the 
promotion risk for acute exposures is perfectly linear down to a dose near zero, the linear 
no-threshold hypothesis. Various biological processes could compete with or nullify the 
ionizing radiation promotion process for these relatively small individual acute exposures. 
There seems to be considerable evidence there is no significant risk at very low acute doses, 
and some possible beneficial effects. 
8. Discussion 
An important observation is that the dose-response relationships for protracted exposures to 
internally deposited radionuclides are quite different from the observed effects of a single 
high dose rate exposure as experienced by the atomic bomb survivors in temporal 
manifestation and preciseness of the effect. In the internal emitter studies the time to cancer 
development depends on the lifetime average dose rate and the cases are not randomly 
distributed with respect to time but rather are tightly grouped over a predictable and 
narrow range of times. At low lifetime average dose rate the time required to develop cancer 
may exceed the natural life span yielding a virtual threshold for cancer induction. 
Bone cancer and lung cancer are equally sensitive in the internal emitter studies with 
beagles, but there is no apparent induction of bone cancer in the atomic bomb survivors 
while there is a considerable increase in lung cancer. The main data are the relative increase 
that suggests radiation promotion was more effective than radiation induction. 
Based on the linear relative risk relationship observed for acute exposure in the RERF 
studies of the atomic bomb survivors, the ICRP developed an absolute risk model for 
radiation-induced cancer as a function of absorbed cumulative ionizing radiation dose that 
was believed to apply to all forms of exposures to ionizing radiation. It is assumed that the 
linear model can predict cancer induction risk but needs a hypothetical dose and dose-rate 
effectiveness correction factor (DDREF) for protracted, fractionated, or low dose exposures. 
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In recognition that protracted or fractionated exposures have been observed to be less 
carcinogenic than the RERF data directly suggest, the ICRP reduced the calculated risk 
using a DDREFof 2, but still assumed lifetime LNT linearity of cancer induction was 
maintained (ICRP 103, 2007). This approach has led to simplistic linear cancer induction risk 
factors such as “ 5% per Sv” (ICRP 60, 1991; ICRP 103, 2007).  
The idea that such a risk factor is valid rests on the assumption that each ionizing-radiation-
induced malignancy is the result of a simple isolated random or “stochastic” initial event 
that is equally probable in any exposed person. Although each malignant tumor is 
monoclonal, the biological processes that lead to that first tumor (and successive tumors) are 
apparently deterministic systemic processes.  
Others have also adopted similar linear cancer induction risk models as a function of 
person-sievert based on the RERF studies. However, as discussed above, these cancer 
inductions models do not apply to non-acute exposures that depend on lifetime average 
dose rate rather than simply on cumulative dose. 
These cancer induction risk models are not valid because of the confusion of cancer 
promotion associated with brief high dose-rate exposures and cancer induction 
associated with protracted exposures. Unfortunately, these misleading cancer induction 
risk values may be used to implement expensive cleanup standards for environmental 
radioactivity.  
The LNT model does not predict the observed effects or lack thereof for protracted 
exposures to ionizing radiation exposure (Jaworowski 2010). The LNT model does not 
readily predict the results of a cumulative set of fractionated medical diagnostic x ray 
exposures of the lung where there was no indication of increased lung cancer with the 
observed relative risk at a cumulative doses of 1 Sv being 1.00 [95% confidence interval 0.94-
1.07] contrasting with the high expected relative risk based on the atomic bomb survivors 
being 1.60 [95% confidence interval 1.27-1.99] (Howe 1995). Also, the large population 
exposures to long-term protracted ionizing radiation associated with the 1986 Chernobyl 
reactor accident in the Ukraine was predicted with LNT to result in a virtual epidemic of 
long term radiation-induced cancer (Anspaugh et al. 1988). Instead, there was no apparent 
major effect of this widespread protracted exposure to ionizing radiation except for thyroid 
disease associated with very high acute radiation doses from short-lived 131I in milk (WHO, 
2006; Jaworowski, 2010). 
Failure to realize the fundamental differences between cancer promotion and cancer 
induction has been the source of scientific misunderstandings and risk estimate 
disagreements. A logical barrier has stood between the linear no-threshold (LNT) model of 
cancer promotion in the acute exposures associated with the Japanese survivors and the 
virtual threshold associated with induction of cancer associated with protracted exposures 
as received from long-lived internally deposited radionuclides in humans or animals. 
Further, it has led to a systematic overestimation of cancer induction risk from protracted 
exposures to ionizing radiation. 
The underlying assumption in these current recommendations is that risk of radiation-
induced cancer is proportional to cumulative dose without threshold. This assumption 
obviously conflicts with the induction of cancer observed in the cases of lifetime protracted 
and repeated exposures to ionizing radiation. An understanding of the source of this conflict 
of data interpretation is essential for sound estimates of cancer risk associated with 
exposures to ionizing radiation. 
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Radiation cancer induction is not a simple stochastic process in the sense that it is not the 
result of a random radiation event in a single cell that converts it into some kind of pre-
malignant neoplastic cell. In reality, both radiation promoted and radiation-induced cancers 
are the result of complex biological processes involving multiple cellular events. These 
events include but are not limited to intercellular communication in irradiated tissues, up-
regulation and down-regulation of genes, DNA mutations, cell division rates, clonal 
expansion of altered cells, and various responses to numerous specific radiation events such 
as DNA double-strand breaks. Induced cancer risk from protracted radiation exposures of 
body organs depends on the lifetime average dose rate to the irradiated organs rather than 
on some function of cumulative dose. The middle Twentieth Century radiation protection 
standards promulgated by the ICRP were properly focused on minimizing dose rate (ICRP 
2, 1959). 
9. Conclusion 
Clearly the development of a radiation-induced malignant tumor from either protracted 
ionizing radiation exposures or acute exposures is not the result of a single random 
interaction of the ionizing radiation with an isolated cell. Hence, the term stochastic as used 
by the ICRP is not appropriate. The following conclusions indicate that major revisions of 
methodology and standards are needed and other currently accepted ionizing radiation risk 
models should be improved to provide more meaningful and realistic estimates of ionizing 
radiation cancer risk: 
(1) Cancer induction risk associated with protracted or fractionated ionizing radiation 
exposure is a non-linear function of lifetime average dose rate to the affected tissues and 
exhibits a virtual threshold at low lifetime average dose rates. (2) Cumulative radiation dose 
is neither an accurate nor an appropriate measure of cancer induction risk for protracted or 
fractionated ionizing radiation exposure except for describing the virtual threshold for 
various exposures. (3) Cancer promotion risk for ongoing lifetime biological processes is a 
relative process as seen in the RERF studies of the Japanese atomic bomb survivors for brief 
high dose-rate exposures to ionizing radiation. It cannot be used to estimate cancer 
induction risk from protracted or fractionated ionizing radiation exposures over long times 
and at low dose rates.  
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